Cargando…

Development of 2-chloroquinoline based heterocyclic frameworks as dual inhibitors of SARS-CoV-2 M(Pro) and PL(Pro)

Evolution of new variants of SARS-CoV-2 warrant the need for the continued efforts in identifying target-oriented new drugs. Dual targeting agents against M(Pro) and PL(Pro) not only overcome the incomplete efficacy but also the drug resistance, which is common problem. Since both these are cysteine...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kattula, Bhavita, Reddi, Bharati, Jangam, Aruna, Naik, Lekhika, Adimoolam, Bala Manikanta, Vavilapalli, Suresh, Are, Sayanna, Thota, Jagadeshwar Reddy, Jadav, Surender Singh, Arifuddin, Mohammed, Addlagatta, Anthony
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171901/ https://www.ncbi.nlm.nih.gov/pubmed/37172706 http://dx.doi.org/10.1016/j.ijbiomac.2023.124772

Ejemplares similares

Anti-inflammatory and antioxidant activities of Gymnema Sylvestre extract rescue acute respiratory distress syndrome in rats via modulating the NF-κB/MAPK pathway
por: Jangam, Aruna, et al.
Publicado: (2023)

Alterations in the pH of pancreatic juice are associated with chymotrypsin C inactivation and lithostathine precipitation in chronic pancreatitis patients: a proteomic approach
por: Goudshelwar, Renuka, et al.
Publicado: (2022)

Virtual high throughput screening: Potential inhibitors for SARS-CoV-2 PL(PRO) and 3CL(PRO) proteases
por: Jade, Dhananjay, et al.
Publicado: (2021)

Discovery of PL(pro) and M(pro) Inhibitors for SARS-CoV-2
por: Puhl, Ana C., et al.
Publicado: (2023)

Synthetic and Medicinal Chemistry Approaches Toward WEE1 Kinase Inhibitors and Its Degraders
por: Alli, Vidya Jyothi, et al.
Publicado: (2023)

“Identification of Nafamostat and VR23 as COVID-19 drug candidates by targeting 3CL(pro) and PL(pro)"
por: Bhowmik, Deep, et al.
Publicado: (2021)

2-Chloroquinoline-3-carbaldehyde
por: Khan, F. Nawaz, et al.
Publicado: (2009)

Spatial and temporal roles of SARS‐CoV PL(pro)—A snapshot
por: Yan, Shaomin, et al.
Publicado: (2020)

SARS-CoV-PL(pro)-Inhibitoren als mögliche Breitspektrum-Virostatika
por: Hammerschmidt, Stefan Josef, et al.
Publicado: (2021)

In silico study of natural compounds from sesame against COVID-19 by targeting M(pro), PL(pro) and RdRp
por: Allam, Ahmed E., et al.
Publicado: (2021)

2-Chloroquinoline-3-carboxylic acid
por: Ladraa, Souheila, et al.
Publicado: (2010)

Exo-selective intermolecular Diels–Alder reaction by PyrI4 and AbnU on non-natural substrates
por: Kashyap, Rajnandani, et al.
Publicado: (2021)

FlipGFP protease assay for evaluating in vitro inhibitory activity against SARS-CoV-2 M(pro) and PL(pro)
por: Tan, Haozhou, et al.
Publicado: (2023)

In Silico and In Vitro Inhibition of SARS-CoV-2 PL(pro) with Gramicidin D
por: Protić, Sara, et al.
Publicado: (2023)

Pro-resolving and anti-arthritic properties of the MC(1) selective agonist PL8177
por: Garrido-Mesa, Jose, et al.
Publicado: (2022)

An overview of potential inhibitors targeting non-structural proteins 3 (PL(pro) and Mac1) and 5 (3CL(pro)/M(pro)) of SARS-CoV-2
por: Yan, Fangfang, et al.
Publicado: (2021)

6-Chloroquinolin-2(1H)-one
por: Zhang, Chen-Guang, et al.
Publicado: (2011)

Diphenyl Diselenide and SARS-CoV-2: in silico Exploration of the Mechanisms of Inhibition of Main Protease (M(pro)) and Papain-like Protease (PL(pro))
por: Omage, Folorunsho Bright, et al.
Publicado: (2023)

N-(2-Chloroquinolin-3-ylmethylene)aniline
por: Kalkhambkar, Rajesh G., et al.
Publicado: (2007)

Dual targeting of 3CL(pro) and PL(pro) of SARS-CoV-2: A novel structure-based design approach to treat COVID-19
por: Rajpoot, Sajjan, et al.
Publicado: (2020)

Effects of diarylbutane lignans from Schisandra chinensis fruit on SARS-CoV-2 3CL(pro) and PL(pro) and their in vitro anti-inflammatory properties
por: Li, Bin, et al.
Publicado: (2023)

MERS‐CoV papain-like protease (PL(pro)): expression, purification, and spectroscopic/thermodynamic characterization
por: Malik, Ajamaluddin, et al.
Publicado: (2017)

Potential COVID-19 papain-like protease PL(pro) inhibitors: repurposing FDA-approved drugs
por: Kouznetsova, Valentina L., et al.
Publicado: (2020)

Potential inhibitors of SARS-CoV-2 (COVID 19) proteases PL(pro) and M(pro)/ 3CL(pro): molecular docking and simulation studies of three pertinent medicinal plant natural components
por: Verma, Devvret, et al.
Publicado: (2021)

In silico studies of M(pro) and PL(pro) from SARS-CoV-2 and a new class of cephalosporin drugs containing 1,2,4-thiadiazole
por: Delgado, Cássia Pereira, et al.
Publicado: (2022)

Schaftoside inhibits 3CL(pro) and PL(pro) of SARS-CoV-2 virus and regulates immune response and inflammation of host cells for the treatment of COVID-19
por: Yi, Yang, et al.
Publicado: (2022)

5-Chloroquinolin-8-yl furan-2-carboxylate
por: Moreno-Fuquen, Rodolfo, et al.
Publicado: (2013)

Sublimable chloroquinolinate lanthanoid single-ion magnets deposited on ferromagnetic electrodes
por: Miralles, Sara G., et al.
Publicado: (2017)

7-Chloroquinolin-4-yl Arylhydrazone Derivatives: Synthesis and Antifungal Activity
por: Duval, Auri R., et al.
Publicado: (2011)

Recent advances in the chemistry of 2-chloroquinoline-3-carbaldehyde and related analogs
por: Hamama, Wafaa S., et al.
Publicado: (2018)

3CL(pro) and PL(pro) affinity, a docking study to fight COVID19 based on 900 compounds from PubChem and literature. Are there new drugs to be found?
por: Štekláč, Marek, et al.
Publicado: (2021)

Computer-aided drug design for the pain-like protease (PL(pro)) inhibitors against SARS-CoV-2
por: Gao, Hongwei, et al.
Publicado: (2023)

Predictive Model for Preeclampsia Combining sFlt-1, PlGF, NT-proBNP, and Uric Acid as Biomarkers
por: Garrido-Giménez, Carmen, et al.
Publicado: (2023)

Structural Insight into the Binding of Cyanovirin-N with the Spike Glycoprotein, M(pro) and PL(pro) of SARS-CoV-2: Protein–Protein Interactions, Dynamics Simulations and Free Energy Calculations
por: Naidoo, Devashan, et al.
Publicado: (2021)

Ebselen derivatives inhibit SARS-CoV-2 replication by inhibition of its essential proteins: PL(pro) and M(pro) proteases, and nsp14 guanine N7-methyltransferase
por: Zmudzinski, Mikolaj, et al.
Publicado: (2023)

Fluorine Atoms on C(6)H(5)-Corrole Affect the Interaction with M(pro) and PL(pro) Proteases of SARS-CoV-2: Molecular Docking and 2D-QSAR Approaches
por: Chaves, Otávio Augusto, et al.
Publicado: (2022)

Polyphenolic Compounds Isolated from Marine Algae Attenuate the Replication of SARS-CoV-2 in the Host Cell through a Multi-Target Approach of 3CL(pro) and PL(pro)
por: Nagahawatta, D. P., et al.
Publicado: (2022)

Virtual screening based on the structure of more than 10(5) compounds against four key proteins of SARS-CoV-2: M(Pro), S(RBD), RdRp, and PL(pro)
por: Nabati, Farzan, et al.
Publicado: (2022)

Discovery of a New Genetic Variant of Methionine Aminopeptidase from Streptococci with Possible Post-Translational Modifications: Biochemical and Structural Characterization
por: Arya, Tarun, et al.
Publicado: (2013)

Synthesis of (2-chloroquinolin-3-yl)-1,3,4-thiadiazole-2-carboxamides
por: Aksenov, A. N., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lrp23g7a192nvdos4uovogbv9c